(Kanakis & Jones, 2021).

Question Project: Clinical validation of serum IL-8 in colorectal cancer patients and efficacy of CETUX adjuvant treatment(Kanakis & Jones, 2021).Colorectal cancer (CRC) is the third most common cancer and mainly affects the gastrointestinal track with smokingas a risk factor. The clinical diagnosis of this type of malignancy relies on colonoscopy but often imaging techniques,such as CT and MRI, can be applied. Carcinoembryonic Antigen (CEA) has been used as a serum tumour marker for thediagnosis of CRC, showing a sensitivity of 17.4 % to 100 % and specificity ranging from 66.1 % to 98.4 % (Sørensen etal., 2016) which underlies that in some cases it is not a reliable diagnostic biomarker. In the recent years, there is aneffort of developing interleukin 8 (IL-8) as a valuable serum biomarker for the early detection of CRC (Lee et al., 2012).Construct one summative table to describe the data (mean ± SE), identify any significant differences between controlsand patients and describe any significant correlations between these biomarkers. Health Science Science Nursing Share QuestionEmailCopy link Comments (0)